Skin Elements Nears Commercial Launch of ECO-Nurture in New Zealand Kiwifruit Sector
Skin Elements Limited advances its proprietary SE Formula biotechnology with ECO-Nurture poised for commercial rollout in 2026, alongside progress in disinfectant and sunscreen product lines.
- ECO-Nurture bio stimulant completes field trials, targeting 2026 NZ kiwifruit rollout
- SuprCuvr plant-based disinfectant gains traction in Australian and NZ markets
- Development of premium SPF50 Soléo Organics sunscreen and UK distribution talks
- Received $117k R&D rebate advance supporting ongoing biotech research
- Quarterly net operating cash outflow of $138k amid active commercialisation efforts
Advancing Natural Biotechnology
Australian biotech company Skin Elements Limited (ASX, SKN) has reported steady progress in its quarterly activity report for the period ending 30 June 2025. Central to its portfolio is the SE Formula, an 18-year research-backed plant-based biotechnology platform underpinning a range of natural products. The company is moving several key products through its three-phase development process, with commercialisation efforts intensifying.
ECO-Nurture, A Sustainable Agricultural Solution
The standout development is ECO-Nurture, a sustainable horticultural bio stimulant designed as a natural alternative to chemical sprays. After three growing seasons of trials on up to 120 kiwifruit orchards in New Zealand, ECO-Nurture has demonstrated positive effects on plant protection and productivity without chemical residues. Skin Elements is now preparing for a commercial rollout in the 2026 New Zealand kiwifruit season, pending final regulatory certification under Zespri’s Crop Protection Standards. Given Zespri’s global influence in the kiwifruit market, this represents a significant commercial opportunity.
Expanding Product Range and Market Reach
Alongside ECO-Nurture, Skin Elements is advancing SuprCuvr, a TGA-registered, hospital-grade disinfectant made entirely from plant-based ingredients. SuprCuvr is currently in use by Spotless cleaning contractors on Melbourne city trains and undergoing trials in New Zealand’s agricultural sector, highlighting its potential in large-scale, chemical-free disinfection markets.
In the personal care segment, the company is developing a premium SPF50 version of its award-winning Soléo Organics sunscreen for the domestic market. Negotiations are underway with a major UK health retail group for white-label distribution, signaling international expansion ambitions.
Financial Position and R&D Investment
Skin Elements received a $117,000 advance on its R&D rebate during the quarter, reflecting ongoing investment in product development. Operational cash outflows totaled $138,000, with expenditures focused on manufacturing, staff, and marketing. The company maintains a $685,000 R&D rebate facility, of which $433,000 has been drawn, providing a financial buffer as it scales commercial activities.
Director payments included $28,000 for services and $140,000 for repayment of R&D-related borrowings, indicating continued alignment of management incentives with company progress.
Looking Ahead
Skin Elements’ methodical advancement through research, testing, and commercial negotiations underscores its commitment to bringing natural, plant-based biotech solutions to market. The upcoming ECO-Nurture rollout in New Zealand’s kiwifruit industry will be a critical milestone, potentially validating the company’s approach and opening doors for broader agricultural applications.
Bottom Line?
As Skin Elements approaches commercialisation milestones, market watchers will keenly observe regulatory approvals and distribution deals that could define its growth trajectory.
Questions in the middle?
- Will ECO-Nurture secure full regulatory approval and widespread adoption in New Zealand’s kiwifruit sector?
- How will negotiations for Soléo Organics’ UK distribution shape international expansion plans?
- Can Skin Elements sustain its R&D investment and manage cashflows amid ongoing operational outflows?
